Selection of the optimal dose for an ultra-short course subcutaneous immunotherapy (SCIT) for Rhinoconjunctivitis for Birch Allergic patients

被引：0
|
作者：
Worm, Margitta [1 ]
Zielen, Stefan [2 ]
Higenbottam, Tim [3 ]
Pfaar, Oliver [4 ]
Mosges, Ralph [5 ]
Aberer, Werner [6 ]
Kramer, Matthias [7 ]
Skinner, Murray [3 ]
Lees, Bev [3 ]
机构：
[1] Charite Univ Med Berlin, Berlin, Germany
[2] Goethe Univ Frankfurt Main, Klinikum Frankfurt 2Univ, Frankfurt, Germany
[3] Allergy Therapeut, Worthing, England
[4] Univ Med Mannheim, Dept Otorhinolaryngol Head & Neck Surg, Mannheim, Germany
[5] Univ Cologne, Cologne, Germany
[6] Med Univ Graz, Dept Dermatol & Venerol, Graz, Austria
[7] Bencard GmbH, Munich, Germany
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2017年 / 139卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2016.12.491
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
478
引用
收藏
页码：AB150 / AB150
页数：1
相关论文
共 50 条
  • [41] Comparison of efficacy of conventional subcutaneous immunotherapy and ultra-short subcutaneous immunotherapy containing monophosphoryl lipid a (MPL): results of a multicentre observational study after 2 years of treatment
    Stollewerk, D.
    Reiber, R.
    Greving, J.
    Walter, S.
    van Braam, R.
    Hegemann-Gaertner, U.
    Stoelzer, k
    Neise, U.
    Kampe, Aufm A.
    Ginko, T.
    ALLERGY, 2010, 65 : 262 - 263
  • [42] Safety and tolerability of an ultra short course subcutaneous immunotherapy formulation in a large randomised phase III trial
    Calderon, M.
    Holdich, T.
    ALLERGY, 2009, 64 : 75 - 75
  • [43] Influence of subcutaneous immunotherapy on the course of allergic rhinitis in patients at high risk of developing bronchial asthma
    Iarmolynska, O.
    Nemyrovska, N.
    Romanuk, L.
    ALLERGY, 2010, 65 : 704 - 705
  • [44] Subcutaneous immunotherapy with mannan-conjugated birch pollen allergoids increases significantly bet v1 specific immunoglobulins in birch pollen allergic patients in a dose-dependent manner
    Raskopf, E.
    Zeyen, C.
    Singh, J.
    Acikel, C.
    Casanovas, M.
    Subiza, Jl
    Allekotte, S.
    Shamji, M.
    Moesges, R.
    ALLERGY, 2021, 76 : 23 - 23
  • [45] Ultra short course specific immunotherapy with pollinex quattro in pediatric and adolescent patients
    Zielen, S.
    Rosewich, M.
    von Weikersthal-Drachenberg, F. K.
    Schulze, J.
    ALLERGY, 2008, 63 : 526 - 526
  • [46] Ultra-short course immunotherapy in children and adolescents during a 3-yrs post-marketing surveillance study
    Rosewich, Martin
    Schulze, Johannes
    von Weikersthal-Drachenberg, Karl J. Fischer
    Zielen, Stefan
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2010, 21 (01) : E185 - E189
  • [47] Subcutaneous Immunotherapy (SCIT) Is Allergen-specific: A Double-blind Trial Of Mite Or Timothy Extract In Mite And Grass Dual Allergic Patients
    Dreborg, S.
    Lee, T.
    Kay, A. B.
    Durham, S. R.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB219 - AB219
  • [48] Effect of Subcutaneous Immunotherapy on The Natural Course of Allergic Diseases in Pediatric Patients: A Real-Life Cohort
    Yilmaz, Ozge
    Yasar, Adem
    Simsek, Yurda
    Alpdogan, Sedef
    Kunay, Bora
    Yuksel, Hasan
    HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI, 2021, 59 (03): : 210 - 215
  • [49] Specific desensitisation against allergy to birch-and grasspollen in patients with seasonal allergic rhinoconjunctivitis and the importance of antibodies to major and minor allergens from birch- and grasspollen concerning the efficacy of immunotherapy
    Sorensen, P.
    Kristiansen, L.
    Staal, A.
    ALLERGY, 2010, 65 : 570 - 570
  • [50] Intra-seasonal short-time up-dosing with SQ-standardised subcutaneous immunotherapy in patients with intermittent allergic rhinoconjunctivitis is well tolerated during routine application
    Reiber, R.
    Wolf, H.
    Schnitker, J.
    Wuestenberg, E.
    ALLERGY, 2011, 66 : 302 - 302
12345